Cargando…

2-Deoxy-2[F-18]FDG-PET for Detection of Recurrent Laryngeal Carcinoma after Radiotherapy: Interobserver Variability in Reporting

PURPOSE: To evaluate accuracy and interobserver variability in the assessment of 2-deoxy-2[F-18]fluoro-d-glucose-positron emission tomography (FDG-PET) for detection of recurrent laryngeal carcinoma after radiotherapy. PROCEDURES: Eleven experienced nuclear physicians from eight centres assessed 30...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Putten, L., Hoekstra, O. S., de Bree, R., Kuik, D. J., Comans, E. F. I., Langendijk, J. A., Leemans, C. R.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2516189/ https://www.ncbi.nlm.nih.gov/pubmed/18622649 http://dx.doi.org/10.1007/s11307-008-0154-3

Ejemplares similares

Interobserver Variability in Chest CT and Whole Body FDG-PET Screening for Distant Metastases in Head and Neck Cancer Patients
por: Senft, Asaf, et al.
Publicado: (2010)

Is C‐11 Methionine PET an alternative to 18‐F FDG‐PET for identifying recurrent laryngeal cancer after radiotherapy?
por: Wedman, Jan, et al.
Publicado: (2018)

The cost-effectiveness of (18)FDG-PET in selecting patients with suspicion of recurrent laryngeal carcinoma after radiotherapy for direct laryngoscopy
por: van Hooren, Addy C. G., et al.
Publicado: (2008)

Large-Vessel Vasculitis: Interobserver Agreement and Diagnostic Accuracy of (18)F-FDG-PET/CT
por: Lensen, K. D. F., et al.
Publicado: (2015)

Salvage surgery in post-chemoradiation laryngeal and hypopharyngeal carcinoma: outcome and review
por: PUTTEN, L., et al.
Publicado: (2015)

2-deoxy-2-[18]fluoro-D-glucose PET/CT (18FDG PET/CT) may not be a viable biomarker in Pompe disease
por: Plöckinger, U., et al.
Publicado: (2018)

Laryngeal Tuberculosis Mimicking Laryngeal Carcinoma on (18)F-FDG PET/CT Imaging
por: Cengiz, Arzu, et al.
Publicado: (2018)

Cost-effectiveness of response evaluation after chemoradiation in patients with advanced oropharyngeal cancer using (18)F–FDG-PET-CT and/or diffusion-weighted MRI
por: Greuter, Marjolein JE, et al.
Publicado: (2017)

Screening for distant metastases in head and neck cancer patients using FDG-PET and chest CT: validation of an algorithm
por: Senft, Asaf, et al.
Publicado: (2015)

Interobserver variability of image-derived arterial blood SUV in whole-body FDG PET
por: Hofheinz, Frank, et al.
Publicado: (2019)

Ferret Thoracic Anatomy by 2-Deoxy-2-(18F)Fluoro-D-Glucose (18F-FDG) Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) Imaging
por: Wu, Albert, et al.
Publicado: (2012)

The adverse impact of surveillance intervals on the sensitivity of FDG-PET/CT for the detection of distant metastases in head and neck cancer patients
por: Senft, Asaf, et al.
Publicado: (2016)

The Additional Value of Ultrafast DCE-MRI to DWI-MRI and 18F-FDG-PET to Detect Occult Primary Head and Neck Squamous Cell Carcinoma
por: Martens, Roland M., et al.
Publicado: (2020)

The effect of substitution therapy on symptoms in patients with hypothyroidism following treatment for laryngeal and hypopharyngeal carcinomas
por: LO GALBO, A.M., et al.
Publicado: (2013)

Assessment of diffuse Lewy body disease by 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET)
por: Mirzaei, Siroos, et al.
Publicado: (2003)

The Prognostic and Diagnostic Value of [(18)F]FDG PET/CT in Untreated Laryngeal Carcinoma
por: Al-Ibraheem, Akram, et al.
Publicado: (2023)

18F‐fluoro‐2‐deoxy‐2‐d‐glucose PET‐CT (FDG PET‐CT) in staging of high‐risk renal and urothelial bladder cancers (COPPER‐T) trial protocol
por: Jena, Rahul, et al.
Publicado: (2023)

Predictive value of quantitative (18)F-FDG-PET radiomics analysis in patients with head and neck squamous cell carcinoma
por: Martens, Roland M., et al.
Publicado: (2020)

(18)F-FDG PET during stereotactic body radiotherapy for stage I lung tumours cannot predict outcome: a pilot study
por: Wiegman, Erwin M., et al.
Publicado: (2011)

Variability in quantitative analysis of atherosclerotic plaque inflammation using (18)F-FDG PET/CT
por: Lensen, Karel-Jan D. F., et al.
Publicado: (2017)

Visual and quantitative evaluation of [(18)F]FES and [(18)F]FDHT PET in patients with metastatic breast cancer: an interobserver variability study
por: Mammatas, Lemonitsa H., et al.
Publicado: (2020)

[(18)F]2-Fluoro-2-deoxy-d-glucose PET/CT in mediastinal masses
por: Rankin, S.
Publicado: (2010)

Precision Radiotherapy: (18)F-FDG PET-based radiotherapy planning in Head and Neck cancers
por: Subramanyam, Padma, et al.
Publicado: (2020)

Observer Variation of 2-Deoxy-2-[F-18]fluoro-d-Glucose-Positron Emission Tomography in Mediastinal Staging of Non-Small Cell Lung Cancer as a Function of Experience, and its Potential Clinical Impact
por: Smulders, Sietske A., et al.
Publicado: (2007)

Prognostic Value of FDG PET Imaging in Patients with Laryngeal Cancer
por: Kitajima, Kazuhiro, et al.
Publicado: (2014)

Is There Any Additional Benefit of Contrast-Enhanced CT as Part of Routine PET/CT Protocols for the Differentiation of Suspicious Incidental Gastrointestinal 2-Deoxy-(18)F-FDG Uptake?
por: Brendle, Cornelia Bettina, et al.
Publicado: (2013)

Using 2-deoxy-2-[(18)F]fluoro-D-glucose ([(18)F]FDG) to study carbon allocation in plants after herbivore attack
por: Meldau, Stefan, et al.
Publicado: (2015)

Comparative Oncology: Evaluation of 2-Deoxy-2-[18F]fluoro-D-glucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) for the Staging of Dogs with Malignant Tumors
por: Seiler, Stefanie M. F., et al.
Publicado: (2015)

Potential of (18)F-FDG PET toward personalized radiotherapy or chemoradiotherapy in lung cancer
por: Choi, Noah C., et al.
Publicado: (2013)

Positron Emission Tomography (PET) radiotracers in oncology – utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC)
por: Miele, Evelina, et al.
Publicado: (2008)

Image findings of cranial nerve pathology on [18F]-2- deoxy-D-glucose (FDG) positron emission tomography with computerized tomography (PET/CT): a pictorial essay
por: Raslan, Osama A., et al.
Publicado: (2015)

18-FDG PET in lung transplantation
por: Algieri, I, et al.
Publicado: (2015)

Myocarditis on (18)FDG-PET imaging
por: Chaaban, Nourhan, et al.
Publicado: (2022)

Monitoring Response to Radiotherapy in Human Squamous Cell Cancer Bearing Nude Mice: Comparison of 2′-deoxy-2′-[(18)F]fluoro-d-glucose (FDG) and 3′-[(18)F]fluoro-3′-deoxythymidine (FLT)
por: Molthoff, Carla F. M., et al.
Publicado: (2007)

2-Deoxy-2-[F-18]fluoro-D-glucose Joint Uptake on Positron Emission Tomography Images: Rheumatoid Arthritis Versus Osteoarthritis
por: Elzinga, E. H., et al.
Publicado: (2007)

Accuracy of [(18)Fluorine]-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography-Computed Tomography Response Assessment Following (Chemo)radiotherapy for Locally Advanced Laryngeal/Hypopharyngeal Carcinoma
por: Slevin, Finbar, et al.
Publicado: (2017)

Optimal 2-[(18)F]fluoro-2-deoxy-d-galactose PET/CT protocol for detection of hepatocellular carcinoma
por: Horsager, Jacob, et al.
Publicado: (2016)

(18) F-FDG PET standard uptake values of the normal pons in children: establishing a reference value for diffuse intrinsic pontine glioma
por: Jansen, Marc H A, et al.
Publicado: (2014)

Prognostic value of pretreatment (18)F-FDG PET-CT in radiotherapy for patients with hepatocellular carcinoma
por: Jo, In Young, et al.
Publicado: (2015)

Prognostic values of mid-radiotherapy (18)F-FDG PET/CT in patients with esophageal cancer
por: Kim, Nalee, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3fnqptv310hjviv8c4p3ngfupm